The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function
Open accessAbstract
Alterations in serotonin (5-hydroxytriptamine, 5-HT), norepinephrine, and gamma-aminobutyric acid have been linked to the pathophysiology of anxiety and depression, and medications that modulate these neurotransmitters are widely used to treat mood disorders. Recently, the neuropeptide substance P (SP) and its receptor, the neurokinin 1 receptor (NK1R), have been proposed as possible targets for new antidepressant and anxiolytic therapies. However, animal and human studies have so far failed to provide a clear consensus on the role of SP in the modulation of emotional states. Here we show that both genetic disruption and acute pharmacological blockade of the NK1R in mice result in a marked reduction of anxiety and stress-related responses. These behavioral changes are paralleled by an increase in the firing rate of 5-HT neurons in the dorsal raphe nucleus, a major source of serotonergic input to the forebrain. NK1R disruption also results in a selective desensitization of 5-HT1A inhibitory autoreceptors, which resembles the effect of sustained antidepressant treatment. Together these results indicate that the SP system powerfully modulates anxiety and suggest that this effect is at least in part mediated by changes in the 5-HT system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,417
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
Holzer, P. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90064-4 · Cited by 1,665
Studies on single neurons in dorsal hippocampal formation and septum in unrestrained rats
Ranck, J. B. (1973) · Experimental Neurology · doi:10.1016/0014-4886(73)90290-2 · Cited by 1,331
Current advances and trends in the treatment of depression
Blier, P., & de Montigny, C. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90315-8 · Cited by 1,113
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors
Kramer, M. S., Cutler, N., Feighner, J., Shrivastava, R., Carman, J., Sramek, J. J., Reines, S. A., Liu, G., Snavely, D., Wyatt-Knowles, E., et al. (1998) · Science · doi:10.1126/science.281.5383.1640 · Cited by 1,071
Serotonin receptor 1A knockout: An animal model of anxiety-related disorder
Ramboz, S., Oosting, R., Amara, D. A., Kung, H. F., Blier, P., Mendelsohn, M., Mann, J. J., Brunner, D., & Hen, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14476 · Cited by 814
Altered nociception, analgesia and aggression in mice lacking the receptor for substance P
Felipe, C. D., Herrero, J. F., O'Brien, J. A., Palmer, J. A., Doyle, C. A., Smith, A. J. H., Laird, J. M. A., Belmonte, C., Cervero, F., & Hunt, S. P. (1998) · Nature · doi:10.1038/32904 · Cited by 755
ELECTROPHYSIOLOGY OF HIPPOCAMPAL NEURONS: II. AFTER-POTENTIALS AND REPETITIVE FIRING
Kandel, E. R., & Spencer, W. A. (1961) · Journal of Neurophysiology · doi:10.1152/jn.1961.24.3.243 · Cited by 688
Primary afferent tachykinins are required to experience moderate to intense pain
Cao, Y. Q., Mantyh, P. W., Carlson, E. J., Gillespie, A.-M., Epstein, C. J., & Basbaum, A. I. (1998) · Nature · doi:10.1038/32897 · Cited by 597
Pharmacological properties of a potent and selective nonpeptide substance P antagonist.
Garret, C., Carruette, A., Fardin, V, Moussaoui, S., Peyronel, J. F., Blanchard, J. C., & Laduron, P. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10208 · Cited by 425
Pérez, V., Gilaberte, I., Faries, D., Alvarez, E., & Artigas, F. (1997) · The Lancet · doi:10.1016/s0140-6736(96)08007-5 · Cited by 300
Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists
Rupniak, N. M. J., & Kramer, M. S. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01396-6 · Cited by 276
Multiple regulators of ultrasonic vocalization in the infant rat
Hofer, M. A. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00042-9 · Cited by 271
Corticosterone response to the plus-mazeHigh correlation with risk assessment in rats and mice
RODGERS, R., HALLER, J., HOLMES, A., HALASZ, J., WALTON, T., & BRAIN, P. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00140-7 · Cited by 260
Goodwin, G. M., De Souza, R. J., & Green, A. R. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90153-4 · Cited by 252
Bodnoff, S. R., Suranyi-Cadotte, B., Quirion, R., & Meaney, M. J. (1989) · Psychopharmacology · doi:10.1007/bf00442264 · Cited by 221
Rewarding effects of opiates are absent in mice lacking the receptor for substance P
Murtra, P., Sheasby, A. M., Hunt, S. P., & De Felipe, C. (2000) · Nature · doi:10.1038/35012069 · Cited by 208
The tachykinin NK1 receptor in the brain: pharmacology and putative functions
Saria, A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00259-9 · Cited by 204
Bill, D. J., Knight, M., Forster, E. A., & Fletche, A. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12342.x · Cited by 173
Rupniak, N. M. J., Carlson, E. C., Harrison, T., Oates, B., Seward, E., Owen, S., de Felipe, C., Hunt, S., & Wheeldon, A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00052-6 · Cited by 168
Anxiety, motor activation, and maternal–infant interactions in 5HT1B knockout mice.
Brunner, D., Buhot, M. C., Hen, R., & Hofer, M. (1999) · Behavioral Neuroscience · doi:10.1037/0735-7044.113.3.587 · Cited by 168
Teixeira, R. M., Santos, A. R. S., Ribeiro, S. J., Calixto, J. B., Rae, G. A., & De Lima, T. C. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00390-1 · Cited by 166
Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims
Underwood, M. D., Khaibulina, A. A., Ellis, S. P., Moran, A., Rice, P. M., Mann, J. J., & Arango, V. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00043-8 · Cited by 165
Ranck, J. B. (1975) · The Hippocampus · doi:10.1007/978-1-4684-2979-4_7 · Cited by 161
Complications associated with genetic background effects in research using knockout mice
Phillips, T. J., Hen, R., & Crabbe, J. C. (1999) · Psychopharmacology · doi:10.1007/s002130051128 · Cited by 154
Blier, P., & de Montigny, C. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90107-1 · Cited by 151
Lower brainstem catecholamine afferents to the rat dorsal raphe nucleus
Peyron, C., Luppi, P., Fort, P., Rampon, C., & Jouvet, M. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960115)364:3<402::aid-cne2>3.0.co;2-8 · Cited by 149
Blier, P., de Montigny, C., & Tardif, D. (1984) · Psychopharmacology · doi:10.1007/bf00427453 · Cited by 113
Anxiolytic Action of a Neurokinin1 Receptor Antagonist in the Social Interaction Test
File, S. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)90002-2 · Cited by 107
Lucas, J. J., Ségu, L., & Hen, R. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.5.755 · Cited by 92
Berman, R., Anand, A., Cappiello, A., Miller, H., Hu, X. S., Oren, D. A., & Charney, D. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00383-7 · Cited by 78
Effect of neurokinin-1 receptor antagonists on the function of 5-HT and noradrenaline neurons
Haddjeri, N., & Blier, P. U. (2000) · Neuroreport · doi:10.1097/00001756-200004270-00035 · Cited by 47
In vivo electrophysiological examination of 5-HT 2 responses in 5-HT 2C receptor mutant mice
Rueter, L. E., Tecott, L. H., & Blier, P. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900181 · Cited by 42
Aversive effects of the C-fragment of Substance P in the dorsal periaqueductal gray matter
de Araújo, J. E., Huston, J. P., & Brandão, M. L. (1998) · Experimental Brain Research · doi:10.1007/s002210050547 · Cited by 40
Gradin, K. A., Qadri, F., Nomikos, G. G., et al. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90194-9 · Cited by 29
Novel strategies to probe the functions of serotonin receptors
Stark, K. L., Oosting, R. S., & Hen, R. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00040-7 · Cited by 21
Heath, M. J. S., Lints, T., Lee, C. J., & Dodd, J. (1995) · The Journal of Physiology · doi:10.1113/jphysiol.1995.sp020798 · Cited by 19
Cited by
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Neuroendocrine pharmacology of stress
Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914
Preclinical models: status of basic research in depression
Nestler, E. J., Gould, E., & Manji, H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01405-1 · Cited by 558
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Chronic pain, chronic stress and depression: Coincidence or consequence?
Blackburn‐Munro, G., & Blackburn‐Munro, R. E. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.0007-1331.2001.00727.x · Cited by 493
Metadata
- Authors
- Santarelli, L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-01-30
- Volume
- 98
- Issue
- 4
- Pages
- 1912-1917
- ISSN
- 0027-8424 (ISSN-L)
- OpenAlex
- W2154989101
- Cited by
- 303
- References
- 39
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.